This report presents initial findings for developing recommendations about expanded access to the Minnesota All Payer Claims Database (MN APCD) and a road map for developing final recommendations later this year. We present an overview of the MN APCD, provide background information about the emergence of APCDs across the country, document some of the important contributions from research over the years, and sketch out opportunities associated with expanded access to the data for Minnesota. 

This brief relies upon data from the MN APCD and methods developed by the Health Care Cost Institute (HCCI) to produce population-based estimates of spending, prices, and use for medical care and prescription drugs. 

This report presents the results of the Minnesota Department of Health’s (MDH) work in developing annual estimates of the health care costs directly associated with selected chronic conditions and smoking.Treated Chronic Disease Prevalence and Spending in Minnesota: Estimated Spending for 2009, 2017, and 2018, Projected Spending for 2017 Through 2028, Supplemental Appendices (PDF)

This article published in the April 13, 2023 issue of Preventing Chronic Disease uses data from the MN APCD to identify gaps in cardiac rehabilitation use among insured Minnesotans in 2017 and 2018 across insurance types, geographic measures, Social Vulnerability Index quartiles, and comorbidities. 

This article published in the April 21, 2023 issue of JAMA Network Open uses data from the MN APCD to examine insurance transitions after Medicaid disenrollment (between January 1, 2018, and February 28, 2019) in Minnesota. 

This article, first published January 9, 2023 in Health Services Research, uses 2008 to 2015 data from the MN APCD to compare direct-to-consumer telemedicine and in-person visits in rates of testing, follow-up health care use, and quality for urinary tract infections and sinusitis. 

This brief relies upon data from the MN APCD and methods developed by the Health Care Cost Institute (HCCI) to produce population-based estimates of spending, use, and prices for medical care and prescription drugs.Health Care Spending, Prices, and Use in Minnesota: 2017 to 2021 - Supplement (PDF)

This snapshot provides prevalence and demographic information on patients with sickle cell disease and sickle cell trait in Minnesota using the Minnesota All Payer Claims Database (MN APCD) and other data sources. 

This article examines telehealth use among commercially insured and Medicare Advantage patients in Minnesota using 2021 and 2022 data from the Minnesota All Payer Claims Database and publicly available data sources.

This brief relies upon data from the MN APCD and methods developed by the Health Care Cost Institute (HCCI) to produce population-based estimates of spending, utilization, and prices for medical care and prescription drugs.Health Care Spending, Prices, and Utilization in Minnesota: 2018 to 2022—Supplement (PDF)